Motus GI believes that clinical research data is generated in many important avenues such as sponsored trials, investigator-initiated studies (IIS) and real-world evidence endeavors. Each avenue contributes in different ways and specifically, investigator-initiated research allows for industry and the medical community to pursue equally important ideas in a collaborative environment. The value of the scientific research produced by investigators, is key to complementing sponsored research and Motus GI is committed to supporting investigator led initiatives.
Motus GI defines an IIS as a clinical study conceptualized, developed and executed by an independent third-party sponsor. Each IIS must be unsolicited, and conducted without the participation of Motus GI and using the highest level of scientific rigor.